New research examines whether past SARS-CoV-2 infections offer immunity against HKU5-CoV. Learn about cross-protection and potential risks.
Currently browsing: Future
ASSURE In the News
RFK Jr. and HHS: The Latest Impacts on COVID-19 Policies
How is RFK Jr. shaping COVID-19 policy as head of HHS? Learn about vaccine mandates, testing accessibility, and public health shifts under his leadership.
COVID-19 Risks at Large Events: How to Stay Safe in 2025
Large gatherings like the Oscars pose COVID-19 risks. Learn how to protect yourself with vaccines, ventilation, and rapid testing.
Essential COVID-19 Updates for 2025 and Beyond
Stay informed about COVID-19 in 2025, including vaccination updates, emerging variants, and preventive measures to protect your health.
Discovery of HKU5-CoV-2, a Novel Coronavirus in China
In February 2025, researchers at the Wuhan Institute of Virology (WIV) identified a novel bat-derived coronavirus, designated HKU5-CoV-2.
Innovations from COVID-19 That Will Shape the Future
Discover how COVID-19 innovations in health, travel, and technology continue to impact the world, from rapid testing to telemedicine and beyond.
The Evolution of COVID-19 Variants: Increased Infectivity, Severity, or a Path to Endemicity?
Explore how SARS-CoV-2 variants are evolving in terms of transmissibility and impact, and whether COVID-19 is on a trajectory to become an endemic virus.
Implications of U.S. Withdrawal from the World Health Organization
Explore the global health consequences of the United States’ decision to withdraw from the World Health Organization, including funding impacts and pandemic response challenges.
Robert F. Kennedy Jr.’s Confirmation as HHS Secretary: Implications for Vaccines and CDC Operations
Explore the potential impacts of Robert F. Kennedy Jr.’s appointment as HHS Secretary on vaccine policies and CDC operations, amidst concerns over public health initiatives.
Impact of Trump Administration’s Health Cuts on COVID-19 Research and Initiatives
Explore how recent health-related budget cuts by the Trump administration’s Department of Government Efficiency affect COVID-19 initiatives and research efforts.